MELISSA SHELBY: Open Payments
NPI 1861086654 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,539 in 185 payments from 18 companies in 2025. Trend: 2023 $2,752 · 2024 $3,652 · 2025 $3,539
Food & beverage: $3,539
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $585 |
| Axsome Therapeutics, Inc. | 21 | $402 |
| Alkermes, Inc. | 17 | $348 |
| ABBVIE INC. | 16 | $338 |
| Otsuka America Pharmaceutical, Inc. | 24 | $319 |
| Neurocrine BioSciences, Inc. | 15 | $301 |
| Vanda Pharmaceuticals Inc. | 15 | $267 |
| Janssen Pharmaceuticals, Inc | 14 | $245 |
| Supernus Pharmaceuticals, Inc. | 8 | $148 |
| ACADIA Pharmaceuticals Inc | 7 | $123 |
Products named: CAPLYTA, Auvelity, REXULTI, ARISTADA, VRAYLAR, INGREZZA, INVEGA SUSTENNA, FANAPT.
Industry payments across TN — which companies pay providers there.
